This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Contact me when this article is cited  Related Content  • Similar articles in JAMA  Social Bookmarking   What's this?

Marvin MOSER, MD
Yale University School of Medicine Boston

Ray W. Gifford, Jr, MD
Cleveland

JAMA. 1985;253(8):1123.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

To the Editor.—

Holme et al¹ present a subgroup analysis from the Oslo Hypertension Study,² relating coronary events in hypertensive patients with and without ECG abnormalities. These patients were given either a placebo or specific antihypertensive therapy, which included a diuretic in most cases. The authors conclude that in the subgroup of hypertensives with pretreatment abnormal ECGs, the trend toward increased coronary events, which was noted in the Multiple Risk Factor Intervention Trial (MRFIT)³ was also observed in their study. They note, however, that their analysis lacks statistical power because of the small number of men studied and caution that conclusions should be drawn with great care from their data.

Unfortunately, many physicians may not read this article as carefully as they should and may erroneously conclude that the data from MRFIT and the Oslo Study were significant and that the use of diuretics in hypertensive patients . . . [Full Text PDF of this Article]

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?